¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Toxic agent syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • failed back surgery syndrome
    ôÃß¼ö¼úÈÄ¿äÅëÁõÈıº
  • floppy infant syndrome
    Àú±äÀ念¾ÆÁõÈıº
  • false memory syndrome
    °ÅÁþ±â¾ïÁõÈıº
  • fragile X syndrome
    ¿©¸°XÁõÈıº
  • gastrointestinal syndrome
    À§Àå°üÁõÈıº
  • gay bowel syndrome
    µ¿¼º¾ÖÀÚâÀÚÁõÈıº
  • general adaptation syndrome
    Àü½Å¼øÀÀÁõÈıº
  • Goodpasture¡¯s syndrome
    ±ÂÆÄ½ºÃ³ÁõÈıº
  • gray syndrome
    ȸ»öÁõÈıº
  • Guillain-Barre syndrome
    ±æ·©-¹Ù·¹ÁõÈıº
  • Ganser syndrome
    °£ÀúÁõÈıº
  • hypereosinophilic syndrome
    °ú´ÙÈ£»ê±¸ÁõÈıº
  • hyper-IgM syndrome
    °í¸é¿ª±Û·ÎºÒ¸°MÁõÈıº
  • hyperimmunoglobulin E syndrome
    °í¸é¿ª±Û·ÎºÒ¸°EÁõÈıº
  • hyperstimulation syndrome
    °ú´ÙÀÚ±ØÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • clumsy hand syndrome
    ¼­Å÷¼ÕÁõÈıº
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • complex regional pain syndrome
    º¹ÇÕ±¹¼Òµ¿ÅëÁõÈıº
  • compression syndrome
    ¾Ð¹ÚÁõÈıº
  • concentration camp syndrome
    ¼ö¿ë¼ÒÁõÈıº
  • congenital constriction ring syndrome
    ¼±ÃµÇùÂø°í¸®ÁõÈıº
  • cor pulmonale syndrome
    Æó½ÉÀåÁõÈıº, ÇãÆÄ½ÉÀåÁõÈıº
  • cord compression syndrome
    ô¼ö¾Ð¹ÚÁõÈıº
  • cranial nerve syndrome
    ³ú½Å°æÁõÈıº
  • craniofacial syndrome
    ¸Ó¸®¾ó±¼ÁõÈıº
  • cri du chat syndrome
    (¢¡cat¡¯s cry) °í¾çÀÌ¿ïÀ½ÁõÈıº
  • cubital tunnel syndrome
    ÆÈ²ß±¼ÁõÈıº
  • culture-bound syndrome
    ¹®È­±ÇÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Ganser syndrome
    °µ¼­ÁõÈıº.
  • Gardner s syndrome
    °¡¾Æµå³ÊÁõÈıº.
  • Gianotti-Crosti syndrome => infantile papular acrodermatitis
    Àð³ëƼ Å©·Î½ºÆ¼ ÁõÈıº
  • Gilberts syndrome
    Áúº£¸£ÁõÈıº
  • Glucose-galactose malabsorption syndrome
    ±Û·çÄÚ¿À½º-°¥¶ôÅ佺Èí¼öÀå¾ÖÁõÈıº(ýåâ¥î¡äôñøý¦ÏØ)
  • Goldenhars syndrome->oculo-auriculo-vertebral dysplasia
    °ñµçÇÏÁõÈıº
  • Goltzs syndrome => focal dermal hypoplasia
    ±¹¼Ò ÁøÇÇ Çü¼ººÎÀüÁõ
  • Golzs syndrome
    °ñÁî ÁõÈıº
  • Goodpasture s syndrome
    ±¸µåÆÐ½ºÃò¾î ÁõÈıº.
  • Gradenigos syndrome
    Ãßü(÷ºÎ)¿° ÁõÈıº, ±×¶óµ¥´Ï
  • Graham-Little syndrome
    ±×·¹À̾ö ¸®Æ² ÁõÈıº
  • Grey platelet syndrome
    ±×·¹ÀÌÇ÷¼ÒÆÇÁõÈıº
  • Guillain Barre syndrome
    ±æ¶û-¹Ù·¹ ÁõÈıº.
  • Guillain-Barre syndrome
    ±æ¶û-¹Ù·¹ ÁõÈıº
  • HELLP syndrome
    HELLP ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • cholinergic agent
    Äݸ°¼º ¾à¹°(å·Úª)
  • cholinergic blocking agent
    Äݸ°¼ºÂ÷´ÜÁ¦
  • cholinergic blocking agent
    Ç×Äݸ°¼º¾à(ù÷¡­å·), Äݸ°¼º Â÷´Ü<ºÀ¼â>Á¦.
  • clumping-inducing agent
    ÀÀ±«À¯¹ßÁ¦
  • competitive agent
    °æÇÕÁ¦(Ìæùêð¥).
  • competitive blocking agent
    °æÀZ(Ìæî³àõ) Â÷´ÜÁ¦(ó´Ó¨ð¥).
  • competitive blocking agent
    °æÇÕ¼º Â÷´ÜÁ¦.
  • compounding agent =c. ingredient
    ¹èÇÕÁ¦(ÛÕùêî§), Á¶ÇÕÁ¦(ðàùêð¥).
  • contrast agent
    Á¶¿µÁ¦
  • cooling agent
    ³Ã°¢Á¦(ËÄ˧̡).
  • coupling medium ; coupling agent ; couplant
    Àü´Þ¸ÅÁú.
  • cryoprotective agent
    µ¿ÇعæÁöÁ¦, ³Ãµ¿»óÇØ¹æÁöÁ¦
  • cryoprotective agent
    µ¿ÇعæÁöÁ¦
  • cryoprotective agent
    µ¿Çغ¸È£¾à(ËÄÌ´ËÓÌ´Ëâ).
  • cryoprotective agent
    µ¿Çغ¸È£¾à(µ¿Çغ¸È£¾à).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
PPA palpation, percussion, auscultation; pepsin A; phenylpropanolamine; phenylpyruvic acid; Pittsburgh p...
PTFA prothrombin time fixing agent
RTP radiation treatment planning; renal transplantation patient; reverse transcriptase-producing [agent]...
SAT saliva alcohol test; satellite; serum antitrypsin; single-agent chemotherapy; slide agglutination te...
VA vacuum aspiration; valproic acid; vasodilator agent; ventricular aneurysm; ventricular arrhythmia; v...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
BCNS Basal Cell Nevus Syndrome
BWS Beckwith Wiedemann Syndrome
BS Behcet's Syndrome
BSS Bernard Soulier Syndrome
BPES Blepharophimosis Ptosis Epicanthus inversus Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carotid sinus syndrome
    °æµ¿¸Æµ¿ ÁõÈıº
  • carpal tunnel syndrome
    ¼ö±Ù°ü ÁõÈıº, ÆÈ¸ñ ÅͳΠÁõÈıº
    1. ¼Õ°¡¶ôÀ» Á¶ÀýÇÏ´Â Àδ븦 µÑ·¯½Î´Â Ȱ¸·ÀÌ ÀÚ±ØÀ» ¹Þ°Å³ª ¿°ÁõÀÌ »ý±ä °Í. ÆÈ¸ñ ÅͳΠÁõÈıºÀº ¼ÕÀ¸·Î ÀÛ¾÷À» ÇÏ´Â »ç¶÷µé ƯÈ÷ °Ç¹Ý ¾Ç±â¸¦ ¿¬ÁÖ°¡, ŸÀÚ¼ö ±×¸®°í ÀÚ·á °ü¸®ÀÚ µî°ú °°Àº »ç¶÷¿¡°Ô Àå¾Ö°¡ ¹ß»ýÇÑ´Ù. 2. ¼ö±Ù°ü³» Á¤Áß ½Å°æÀÌ ¾Ð¹ÚµÉ ¶§ ÀϾ´Â ÁõÈıºÀ¸·Î¼­, ¼Õ°¡¶ôÀÇ µ¿Åë, ÀÛ¿­°¨ ±×¸®°í ÀÌ»ó °¨°¢À» µ¿¹ÝÇϸç, ¶§·Î´Â ÆÈ²ÞÄ¡±îÁö ÆÄ±ÞµÈ´Ù. 3. ¼ö±Ù°üÀº ¼Õ¸ñÀÇ ¼öÀåºÎ¿¡ À§Ä¡Çϸç, ¹èÃø°ú Ãøº®Àº ¼ö±Ù°ñ·Î ±¸¼ºµÇ°í, º¹ÃøÀº ´Ü´ÜÇÑ ¼¶À¯¼º Ⱦ¼ö±Ù Àδë·Î µ¤Çô ÅͳÎÀ» Çü¼ºÇÑ´Ù. Åͳγ»¿¡´Â Á¤Áß ½Å°æ, õÁö±¼±Ù, ½ÉÁö±¼±Ù, À幫Áö±¼±ÙÀÌ Åë°úÇϴµ¥ Á¤Áß ½Å°æÀÇ ¾Ð¹ÚÀ¸·Î ¹ß»ýÇÏ´Â ÁõÈıºÀÌ´Ù.
  • Carpenter syndrome
    Ä«¾ÆÆæÅÍ ÁõÈıº
    ÷µÎ, ´ÙÁö ÇÕÁöÁõ, ´ÜÁöÁõ, ÀÌ»ó ¾È¸é, ºñ¸¸Áõ, Áö´ÉÀúÇÏ, ¼º¼± ±â´É ºÎÀüÀ» µ¿¹ÝÇÏ´Â »ó¿°»öü ¿­¼º À¯Àü¼º ÁõÈıº.
  • cartoid sinus syndrome
    °æµ¿¸Æµ¿ ÁõÈıº
  • catcry syndrome
    ¹¦¼º ÁõÈıº
  • cauda equina syndrome
    ¸¶¹Ì ÁõÈıº
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¼º ¸é¿ª °áÇÌ ÁõÈıº
  • cerebrohepatorenal syndrome
    ³ú°£ ½Å ÁõÈıº
  • cervical fusion syndrome
    °æºÎ À¯ÇÕ ÁõÈıº
  • cervicobrachial syndrome
    °æ »ó¿Ï ÁõÈıº
  • Cestans syndrome
    ¼¼½ºÅº ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµå ÁõÈıº
  • chiasmal syndrome
    ½Ã ½Å°æ ±³Â÷ºÎ ÁõÈıº
  • Chilaiditis syndrome
    ų¶óÀÌµðÆ¼ ÁõÈıº
    °áÀå ¶Ç´Â ¼ÒÀåÀÇ ÀϺΰ¡ °£°ú Ⱦ°æ¸· »çÀÌ¿¡ °¨µ·ÇÏ¿© ÀϾ´Â ÁõÈıº.
  • cholecysto-hepatic flexure adhesion syndrome
    ´ã³¶ °áÀå °£°îºÎ À¯Âø ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
antibody deficiency syndrome <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
antiphospholipid antibody syndrome <syndrome> An immune disorder characterised by the presence of abnormal antibodies in the blood associated with certain medical conditions including abnormal blood clotting, migraine headaches, premature miscarriage, and low blood platelet counts (thrombocytopenia).
(12 Dec 1998)
antiphospholipid syndrome <immunology, syndrome> An uncommon disorder that is characterised by hypercoagulability due to the presence of antibodies against phospholipids.
These patients exhibit a tendency for recurrent and life-threatening thrombosis and embolic events (for example stroke). Individuals with antiphospholipid syndrome also have an increased tendency toward deep venous thrombosis, myocardial infarction and spontaneous abortions in females.
Antiphospholipid syndrome may be seen by itself or in association with other autoimmune illnesses (for example lupus) or with some infections.
Treatment includes long-term heparin and warfarin.
(13 Jan 1998)
Anton's syndrome <syndrome> In cortical blindness, lack of awareness of being blind.
(05 Mar 2000)
anxiety syndrome <syndrome> The constellation of autonomic nervous system signs and symptoms accompanying the apprehension of danger and dread.
See: anxiety.
(05 Mar 2000)
aortic arch syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
apallic syndrome Diffuse, bilateral cerebral cortical degeneration caused by head injury, anoxia, or encephalitis, a state of persistent unresponsiveness, such as akinetic mutism, caused by brain damage.
See: vegetative.
Synonym: apallic syndrome, apallic.
(05 Mar 2000)
Apert's syndrome <paediatrics> A usually inherited disorder characterised by premature closing of the cranial suture lines resulting in a peaked shaped head and abnormal facial appearance.
Since it is usually autosomal dominant one or both parents also have the disorder. Surgery is used to correct skull and facial abnormalities.
Inheritance: autosomal dominant.
(29 Dec 1997)
Apert syndrome <syndrome> Apert (1906) defined a syndrome characterised by skull malformation (acrocephaly of brachysphenocephalic type) due to the premature closure of the cranial sutures and syndactyly of the hands and feet of a special type (complete distal fusion with a tendency to fusion also of the bony structures). The hand, when all the fingers are webbed, has been compared to a spoon and, when the thumb is free, to an obstetric hand.
Two clinical categories are distinguished, a 'typical' acrocephalosyndactyly, to which Apert's name is appropriately applied and other forms lumped together as 'atypical' acrocephalosyndactyly.
The feature distinguishing the two types is a middigital hand mass with a single nail common to digits 2-4, found in Apert syndrome and lacking in the others. A frequency of Apert syndrome of 1 in 160,000 births is estimated.
Evidence suggests that Apert syndrome results from mutations in the gene encoding fibroblast growth factor receptor-2.
Progressive synostosis occurs in the feet, hands, carpus, tarsus, cervical vertebrae, and skull, and proposed 'progressive synosteosis with syndactyly' is possibly a more appropriate designation.
Clinical features: flat facies, shallow orbits, hypertelorism, narrow palate, craniosynostosis, brachysphenocephalic acrocephaly, syndactyly, broad thumb, broad great toe, single nail digits 2-4, variable mental retardation, corpus callosum and/or limbic malformations, fused cervical vertebrae.
A skull X-ray can confirm the diagnosis. Treatment is surgical.
Inheritance: autosomal dominant, paternal age effect.
(05 Aug 1998)
Argonz-Del Castillo syndrome <syndrome> Unphysiological lactation and amenorrhoea not following pregnancy characterised by hyperprolactinaemia and a pituitary adenoma.
Synonym: Argonz-Del Castillo syndrome.
(05 Mar 2000)
Arndt-Gottron syndrome Generalised lichen myxoedematosus with diffuse thickening of the skin underlying the papules.
Synonym: Arndt-Gottron syndrome.
(05 Mar 2000)
Arnold-Chiari syndrome <radiology> Chiari I herniation of medulla and cerebellar tonsils, 4th ventricle in normal position, Chiari II herniation of medulla, tonsils, vermis, 4th ventricle at foramen magnum, myelomeningocele, aqueductal stenosis most likely to be hydrocephalus, Chiari III further herniation, 4th ventricle below foramen magnum, encephalocele or myelomeningocele associated with: agenesis of corpus callosum, syrinx
(12 Dec 1998)
arterial thoracic outlet syndrome <syndrome> A rare disorder due to compression of the subclavian artery (with resultant poststenotic dilation) by a fully formed cervical rib; thrombi form in the dilated distal arterial segment, and distal limb ischemia may occur due to thromboembolic events.
(05 Mar 2000)
arteriovenous strabismus syndrome <syndrome> Strabismus in which the angle of deviation is more marked on looking upward or downward.
See: A-esotropia, V-esotropia, A-exotropia, V-exotropia.
(05 Mar 2000)
Ascher's syndrome <syndrome> A condition in which a congenital double lip is associated with blepharochalasis and nontoxic thyroid gland enlargement.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á